Exendin-4 vs Insulin Aspart

Head-to-head comparison of Exendin-4 (Exendin-4 (synthetic exenatide)) and Insulin Aspart (Insulin aspart (B28-Asp human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyExendin-4Insulin Aspart
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameExendin-4 (synthetic exenatide)Insulin aspart (B28-Asp human insulin analog)
Molecular Weight4186 Da5825.8 Da
Half-Life2.4 hoursAbout 1-3 hours
Amino Acids3951
Typical Dose5-10 mcg twice daily0.05-0.2 U/kg per meal
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count180011000
Research StatusClinicalApproved

Exendin-4 Benefits

  • beta-cell survival
  • glucose-stimulated insulin secretion
  • reduced glucolipotoxicity
  • lowered HbA1c in clinical use

Insulin Aspart Benefits

  • Fast post-meal glucose lowering
  • Predictable onset
  • Flexible mealtime administration
  • Compatible with pump therapy

Exendin-4 Dosing

5 mcg SC twice daily for 4 weeks|increase to 10 mcg SC twice daily if tolerated|research: 0.1-1 µM in vitro or 1-10 µg/kg in animals

Insulin Aspart Dosing

Inject SC immediately before meals|Titrate using glucose monitoring and carbohydrate intake|Can be used in insulin pumps or basal-bolus regimens

Exendin-4 Side Effects

  • nausea
  • vomiting
  • injection-site reactions

Insulin Aspart Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Research Overview

Exendin-4

Exendin-4 helped establish GLP-1 receptor biology in diabetes and remains a classic beta-cell protective peptide. Preclinical studies show reduced beta-cell apoptosis, improved insulin content, and better islet function under metabolic stress.

Insulin Aspart

Research consistently shows faster onset and earlier peak action than regular human insulin. It is commonly studied for meal-time glycemic control and pump-based insulin delivery.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Exendin-4 stacks with:

SGLT2 inhibitorsDPP-4 inhibitorsdiet and exercise

Insulin Aspart stacks with:

Insulin GlargineInsulin Degludec
GLP-1 agonistbeta-cell protectionincretinrapid-acting insulinmeal coveragepump-compatible